| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-13 23:30:18 UTC |
|---|
| Update Date | 2022-03-07 02:49:21 UTC |
|---|
| HMDB ID | HMDB0004667 |
|---|
| Secondary Accession Numbers | - HMDB0006939
- HMDB0061708
- HMDB0112194
- HMDB04667
- HMDB06939
- HMDB61708
|
|---|
| Metabolite Identification |
|---|
| Common Name | 13-HODE |
|---|
| Description | 13-Hydroxyoctadecadienoic acid (13-HODE) (CAS: 18104-45-5), also known as 13(S)-hydroxy-9Z,11E-octadecadienoic acid or 13(S)-HODE, is the major lipoxygenation product synthesized in the body from linoleic acid. 13-HODE prevents cell adhesion to endothelial cells and can inhibit cancer metastasis. 13-HODE synthesis is enhanced by cyclic AMP. gamma-Linolenic acid, a desaturated metabolite of linoleic acid, causes substantial stimulation of 13-HODE synthesis. A fall in gamma-linolenic acid synthesis with age may be related to the age-related fall in 13-HODE formation (PMID: 9561154 ). 13-HODE is considered an intermediate in linoleic acid metabolism. It is generated from 13(S)-HPODE via the enzyme lipoxygenase (EC 1.13.11.12). 13-HODE has been shown to be involved in cell proliferation and differentiation in a number of systems. 13-HODE is found to be produced by prostate tumours and cell lines and researchers believe that there is a link between linoleic acid metabolism and the development or progression of prostate cancer (PMID: 9367845 ). |
|---|
| Structure | CCCCC[C@H](O)\C=C\C=C/CCCCCCCC(O)=O InChI=1S/C18H32O3/c1-2-3-11-14-17(19)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h7,9,12,15,17,19H,2-6,8,10-11,13-14,16H2,1H3,(H,20,21)/b9-7-,15-12+/t17-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (13S)-Hydroxyoctadecadienoic acid | ChEBI | | (9Z, 11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid | ChEBI | | (9Z,11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid | ChEBI | | (13S)-Hydroxyoctadecadienoate | Generator | | (9Z, 11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoate | Generator | | (9Z,11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoate | Generator | | 13S-Hydroxyoctadecadienoate | HMDB | | 13-Hydroxy-9,11-octadecadienoic acid | HMDB | | 13-Hydroxy-9,11-octadecadienoic acid, (S)-(e,Z)-isomer | HMDB | | 13-Hydroxy-9,11-octadecadienoic acid, (Z,e)-isomer | HMDB | | 13-Hydroxyoctadecadienoic acid | HMDB | | 13-Hydroxy-9,11-octadecadienoic acid, (e,Z)-isomer | HMDB | | 13(S) HODE | HMDB | | 13-Hydroxyoctadecadienoate | HMDB | | (+)-Coriolic acid | HMDB | | (13S,9Z,11E)-13-Hydroxy-9,11-octadecadienoic acid | HMDB | | (9Z,11E)-13-Hydroxy-9,11-octadecadienoic acid | HMDB | | (9Z,11E,13S)-13-Hydroxy-9,11-octadecadienoic acid | HMDB | | (9Z,11E,13S)-13-Hydroxyoctadecadienoic acid | HMDB | | (S)-Coriolic acid | HMDB | | (±)-coriolic acid | HMDB | | 13-Hydroxy-9(Z),11(e)-octadecadienoic acid | HMDB | | 13-Hydroxy-9,11-cis,trans-octadecadienoic acid | HMDB | | 13-Hydroxy-9-cis-11-trans-octadecadienoic acid | HMDB | | 13-Hydroxy-cis-9-trans-11-octadecadienoic acid | HMDB | | 13-Hydroxylinoleic acid | HMDB | | 13-Hydroxyoctadeca-9,11-dienoic acid | HMDB | | 13S-HODE | HMDB | | 13S-Hydroxy-9Z,11E-octadecadienoic acid | HMDB | | L-13-Hydroxy-cis-9,trans-11-octadecadienoic acid | HMDB | | alpha-Artemisolic acid | HMDB | | Α-artemisolic acid | HMDB | | (9Z,11E,13S)-13-Hydroxyoctadeca-9,11-dienoate | HMDB | | (9Z,11E)-13-HODE | HMDB | | (9Z,11E)-13-Hydroxyoctadecadienoic acid | HMDB | | FA(18:2(9Z,11E,13-OH)) | HMDB | | FA(18:2(9Z,11E,13S-OH)) | HMDB | | 13-HODE | HMDB, MeSH |
|
|---|
| Chemical Formula | C18H32O3 |
|---|
| Average Molecular Weight | 296.4449 |
|---|
| Monoisotopic Molecular Weight | 296.23514489 |
|---|
| IUPAC Name | (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid |
|---|
| Traditional Name | 13-hydroxyoctadecadienoic acid |
|---|
| CAS Registry Number | 29623-28-7 |
|---|
| SMILES | CCCCC[C@H](O)\C=C\C=C/CCCCCCCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C18H32O3/c1-2-3-11-14-17(19)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h7,9,12,15,17,19H,2-6,8,10-11,13-14,16H2,1H3,(H,20,21)/b9-7-,15-12+/t17-/m0/s1 |
|---|
| InChI Key | HNICUWMFWZBIFP-IRQZEAMPSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Lineolic acids and derivatives |
|---|
| Direct Parent | Lineolic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Octadecanoid
- Long-chain fatty acid
- Hydroxy fatty acid
- Fatty acid
- Unsaturated fatty acid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter)). Predicted by Afia on May 17, 2022. | 9.12 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 19.7746 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.02 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 35.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 13-HODE,1TMS,isomer #1 | CCCCC[C@@H](/C=C/C=C\CCCCCCCC(=O)O)O[Si](C)(C)C | 2532.1 | Semi standard non polar | 33892256 | | 13-HODE,1TMS,isomer #2 | CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)O[Si](C)(C)C | 2482.1 | Semi standard non polar | 33892256 | | 13-HODE,2TMS,isomer #1 | CCCCC[C@@H](/C=C/C=C\CCCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2543.2 | Semi standard non polar | 33892256 | | 13-HODE,1TBDMS,isomer #1 | CCCCC[C@@H](/C=C/C=C\CCCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 2782.1 | Semi standard non polar | 33892256 | | 13-HODE,1TBDMS,isomer #2 | CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)O[Si](C)(C)C(C)(C)C | 2726.1 | Semi standard non polar | 33892256 | | 13-HODE,2TBDMS,isomer #1 | CCCCC[C@@H](/C=C/C=C\CCCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3044.1 | Semi standard non polar | 33892256 |
|
|---|
| General References | - Horrobin DF, Ziboh VA: The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE. Adv Exp Med Biol. 1997;433:291-4. [PubMed:9561154 ]
- Spindler SA, Sarkar FH, Sakr WA, Blackburn ML, Bull AW, LaGattuta M, Reddy RG: Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun. 1997 Oct 29;239(3):775-81. [PubMed:9367845 ]
- Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, Patel RT, Lee J, Chen S, Peroni OD, Dhaneshwar AS, Hammarstedt A, Smith U, McGraw TE, Saghatelian A, Kahn BB: Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014 Oct 9;159(2):318-32. doi: 10.1016/j.cell.2014.09.035. [PubMed:25303528 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
|---|